Seminar on,
Recent Trends in Pharmaceutical Sciences
(Research Paper Title: Uptake and transport of furanodiene in Caco-2 cell
monolayers: a comparison study between furanodiene and furanodiene
loaded PLGA nanoparticles)
BY:
Nitin P. Kanwale
Roll no. 06
M. Pharm. Sem III
Dept. QAT
UNDER GUIDANCE OF:
Dr. Mrudula H. Bele
(Pharmaceutics department)
MVP Samaj's college of Pharmacy, Nashik
MVP Samaj’s College of
Pharmacy, Nashik05-11-2015 1
1. Drug profile
2. Introduction
3. Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-
NPs:
4. Characterization of FDE-PLGA-NPs And FDE-PEG-
PEGA-NPs:
5. Conclusion
6. References
05-11-2015 2
3
FURANODIENE
Stucture
Chemical name
(5E,9E)-3,6,10-trimethyl-4,7,8,11-
tetrahydrocyclodeca[b]furan
Pharmacological
activities
Anti-tumor, Anti-inflammation.
05-11-2015
RESEARCH QUESTION ?
As it possible to improve the stability and bioavailability of FDE by preparing
FDE loaded PLGA and PEGylated PLGA nanoparticles ?
GOAL OF WORK :
furanodiene has some disadvantages like low aqueous solubility, low
stability, low permeability, uptake by cell so there is need to improve the
stability and oral bioavailability of furanodiene.
Use Caco-2 cell line as a in vitro model to evaluate the response of Caco-2
cells to FDE, FDE-PLGA-NPs and FDE-PEG-PLGA-NPs to compare the
capacity of the carrier to mediate FDE transport across cell monolayers.
405-11-2015
• By using modified spontaneous emulsion solvent diffusion
method:
3 mg furanodiene+25 mg PLGA(PEG-PLGA) dissolved in 2 ml acetone
slowelly injected into
15 ml of 0.2% tween80 solution
magnetic stirring at room temp. to evaporate the organic
solvent.
nanoparticle suspension was collected by centrifugation(15000 rpm/min.)
wash 3 times by using deionized water to remove
excessive
emulsifier.
nanoparticle suspension then freeze dried to obtain a fine power of
nanoparticle.
05-11-2015 5
• 4.1Nanoparticle size, size distribution, zeta potential, surface morphology,
entrapment efficiency:
EE= (T-F) /T×100
Where: T= total amount of furanodiene added
F= free furanodiene amount in the supernatant
Table1: Characteristics of the nanoparticles
Fig. 1 Scanning electron microscope (SEM) images of the nanoparticles. Scale bar = 200 nm. (a) FDE-PLGA-NPs,
(b) FDE-PEG-PLGA-NPs
05-11-2015 6
05-11-2015 7
Fig. 2: Stabilities of FDE, FDE-PLGA-NPs and FDE-PEG-PLGA- Fig. 3: Stabilities of FDE, FDE-PLGA-
NPs and FDE-
NPs in PBS (pH 7.4). PEG-PLGA-NPs in artificial gastric
fluids.
Fig. 4: Stabilities of FDE, FDE-PLGA-NPs and FDE-PEG-PLGA-NPs in artificial
intestinal fluids.
Fig. 5: The cytotoxicity of FDE, FDE-PLGA-NPs and FDE-PEG-PLGA-NPs.
Caco-2 cells were incubated with sample solutions (1 to 40 μg−1 of FDE) for
6 h. Cell viability was determined by MTT assay.
05-11-2015 8
Fig. 6: Quantitative analysis of FDE cellular uptake. Caco-2 cells were
incubated with sample solutions (15 μg·mL−1 of FDE) for different durations.
Intracellular FDE was assayed by RP-HPLC.
05-11-2015 9
Where: Papp= Apparent permeability coefficient
dq= amount of FDE in the receptor compartment at time t.
A = diffusion area
C0 = initial concentration of FDE in the donor compartment.
05-11-2015 10
Papp=
𝑑𝑄
𝑑𝑡
×
1
𝐴×𝐶0
Fig. 7: Transport of FDE across Caco-2 cell monolayers (AP to BL ).
Fig. 9: Transport of FDE across Caco-2 cell monolayers (BL to AP ).
05-11-2015 11
These results indicated that FDE-PLGA-NPs, especially
FDE-PEG-PLGA-NPs, could enhance the stability and
hydrophilicity of FDE and increase the permeation of FDE
across Caco-2 cell monolayers.
05-11-2015 12
OVER VIEW:
POSITIVE POINT:
NEGATIVE POINT:
1. Gang L, Dong-hai L, Xin-xin X, Li-fang Q, Jun-teng W, Ke L. Uptake
And Transport Of Furanodiene In Caco-2 Cell Monolayers: A
Comparison Study Between Furanodiene And Furanodiene Loaded
PLGA Nanoparticles. Chinese Journal Of Natural
Medicines2013;11(1):049-055.
05-11-2015 13
14
05-11-2015

ppt on published research paper

  • 1.
    Seminar on, Recent Trendsin Pharmaceutical Sciences (Research Paper Title: Uptake and transport of furanodiene in Caco-2 cell monolayers: a comparison study between furanodiene and furanodiene loaded PLGA nanoparticles) BY: Nitin P. Kanwale Roll no. 06 M. Pharm. Sem III Dept. QAT UNDER GUIDANCE OF: Dr. Mrudula H. Bele (Pharmaceutics department) MVP Samaj's college of Pharmacy, Nashik MVP Samaj’s College of Pharmacy, Nashik05-11-2015 1
  • 2.
    1. Drug profile 2.Introduction 3. Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA- NPs: 4. Characterization of FDE-PLGA-NPs And FDE-PEG- PEGA-NPs: 5. Conclusion 6. References 05-11-2015 2
  • 3.
  • 4.
    RESEARCH QUESTION ? Asit possible to improve the stability and bioavailability of FDE by preparing FDE loaded PLGA and PEGylated PLGA nanoparticles ? GOAL OF WORK : furanodiene has some disadvantages like low aqueous solubility, low stability, low permeability, uptake by cell so there is need to improve the stability and oral bioavailability of furanodiene. Use Caco-2 cell line as a in vitro model to evaluate the response of Caco-2 cells to FDE, FDE-PLGA-NPs and FDE-PEG-PLGA-NPs to compare the capacity of the carrier to mediate FDE transport across cell monolayers. 405-11-2015
  • 5.
    • By usingmodified spontaneous emulsion solvent diffusion method: 3 mg furanodiene+25 mg PLGA(PEG-PLGA) dissolved in 2 ml acetone slowelly injected into 15 ml of 0.2% tween80 solution magnetic stirring at room temp. to evaporate the organic solvent. nanoparticle suspension was collected by centrifugation(15000 rpm/min.) wash 3 times by using deionized water to remove excessive emulsifier. nanoparticle suspension then freeze dried to obtain a fine power of nanoparticle. 05-11-2015 5
  • 6.
    • 4.1Nanoparticle size,size distribution, zeta potential, surface morphology, entrapment efficiency: EE= (T-F) /T×100 Where: T= total amount of furanodiene added F= free furanodiene amount in the supernatant Table1: Characteristics of the nanoparticles Fig. 1 Scanning electron microscope (SEM) images of the nanoparticles. Scale bar = 200 nm. (a) FDE-PLGA-NPs, (b) FDE-PEG-PLGA-NPs 05-11-2015 6
  • 7.
    05-11-2015 7 Fig. 2:Stabilities of FDE, FDE-PLGA-NPs and FDE-PEG-PLGA- Fig. 3: Stabilities of FDE, FDE-PLGA- NPs and FDE- NPs in PBS (pH 7.4). PEG-PLGA-NPs in artificial gastric fluids. Fig. 4: Stabilities of FDE, FDE-PLGA-NPs and FDE-PEG-PLGA-NPs in artificial intestinal fluids.
  • 8.
    Fig. 5: Thecytotoxicity of FDE, FDE-PLGA-NPs and FDE-PEG-PLGA-NPs. Caco-2 cells were incubated with sample solutions (1 to 40 μg−1 of FDE) for 6 h. Cell viability was determined by MTT assay. 05-11-2015 8
  • 9.
    Fig. 6: Quantitativeanalysis of FDE cellular uptake. Caco-2 cells were incubated with sample solutions (15 μg·mL−1 of FDE) for different durations. Intracellular FDE was assayed by RP-HPLC. 05-11-2015 9
  • 10.
    Where: Papp= Apparentpermeability coefficient dq= amount of FDE in the receptor compartment at time t. A = diffusion area C0 = initial concentration of FDE in the donor compartment. 05-11-2015 10 Papp= 𝑑𝑄 𝑑𝑡 × 1 𝐴×𝐶0
  • 11.
    Fig. 7: Transportof FDE across Caco-2 cell monolayers (AP to BL ). Fig. 9: Transport of FDE across Caco-2 cell monolayers (BL to AP ). 05-11-2015 11
  • 12.
    These results indicatedthat FDE-PLGA-NPs, especially FDE-PEG-PLGA-NPs, could enhance the stability and hydrophilicity of FDE and increase the permeation of FDE across Caco-2 cell monolayers. 05-11-2015 12 OVER VIEW: POSITIVE POINT: NEGATIVE POINT:
  • 13.
    1. Gang L,Dong-hai L, Xin-xin X, Li-fang Q, Jun-teng W, Ke L. Uptake And Transport Of Furanodiene In Caco-2 Cell Monolayers: A Comparison Study Between Furanodiene And Furanodiene Loaded PLGA Nanoparticles. Chinese Journal Of Natural Medicines2013;11(1):049-055. 05-11-2015 13
  • 14.